Design and synthesis of nanoscaled IQCA-TAVV as a delivery system capable of antiplatelet activation, targeting arterial thrombus and releasing IQCA
Jianhui Wu,1,2,* Haimei Zhu,1,2,* Guodong Yang,1 Jianhong He,3 Yuji Wang,1,2 Shurui Zhao,1,2 Xiaoyi Zhang,1,2 Lin Gui,1,2 Ming Zhao,1,2,4 Shiqi Peng1,2 1Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, Engineering Research Center of Endogenous Prophylactic of Ministry of Educatio...
Guardado en:
Autores principales: | Wu J, Zhu H, Yang G, He J, Wang Y, Zhao S, Zhang X, Gui L, Zhao M, Peng S |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/408fb8d8bcf6477da84f7fa4ba80251e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Proteoglycan Biglycan Modulates Platelet Adhesion and Thrombus Formation in a GPVI-Dependent Manner
por: Henrike Hoermann, et al.
Publicado: (2021) -
Thrombus-Targeting Polymeric Nanocarriers and Their Biomedical Applications in Thrombolytic Therapy
por: Qixiao Guan, et al.
Publicado: (2021) -
Nano-scaled MTCA-KKV: for targeting thrombus, releasing pharmacophores, inhibiting thrombosis and dissolving blood clots in vivo
por: Zhao S, et al.
Publicado: (2019) -
The P2Y12 Receptor Antagonist Selatogrel Dissolves Preformed Platelet Thrombi In Vivo
por: Lydie Crescence, et al.
Publicado: (2021) -
Tratamiento quirúrgico de la isquemia mesentérica crónica: Caso clínico
por: Marín P,Juan, et al.
Publicado: (2007)